Cannabis Sativa, Inc. (OTCMKTS:CBDS) Files An 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers

ME Staff 8-k
-
0
Cannabis Sativa, Inc. (OTCMKTS:CBDS) Files An 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers

Cannabis Sativa, Inc. (OTCMKTS:CBDS) Files An 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers
ITEM 5.02 Departure of Chief Executive Officer.

The Registrant (“Company”) is announcing today the retirement of its CEO, Mr. Mike Gravel. Mr. Gravel will continue to serve as a member of the board of directors until the Company’s next annual meeting of shareholders. The duties of CEO are being assumed by Mr. David Tobias who presently serves as the president and secretary of the Company. Biographical information for Mr. Tobias can be viewed on page 21 of the Company’s Annual Report on Form 10-K filed with the Securities and Exchange Commission on April 4, 2018. Mr. Gravel has served long and well as the Company’s CEO and will turn 90 years old later this year. He has decided it is time to step down and pursue other interests. The Company has great appreciation for the service he has given and wishes him well in his retirement.

PAGE

About Cannabis Sativa, Inc. (OTCMKTS:CBDS)

Cannabis Sativa, Inc. develops and promotes natural cannabis products. The Company is engaged in the research, development and licensing of natural cannabis products, including cannabis formulas, edibles, topicals, strains, recipes and delivery systems. The Company plans to develop, produce and market products through joint ventures with companies licensed under state regulations applicable to cannabis businesses. It holds the license for a medicinal cannabis strain called NZT, a cannabis lozenge delivery methodology, and a cannabis trauma cream formula. The Company is also developing a third strain of cannabis plant named CT22. The Company also conducts its operations through its subsidiary, Wild Earth Naturals, Inc. (Wild Earth). Wild Earth is an herbal skin care products formulation and marketing company that plans to target the natural healthcare products market in the United States and abroad. It offers Go Deep, Go Deep EXTRA (GDX), Face Garden, Body Garden and Lip Garden.